MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Show more

Location: 9713 KEY WEST AVENUE, ROCKVILLE, MD, UNITED STATES, 20850, Rockville, MD, 20850, USA | Website: https://www.maxcyte.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE


Market Cap

86.19M

52 Wk Range

$0.75 - $4.42

Previous Close

$0.81

Open

$0.81

Volume

1,746,337

Day Range

$0.78 - $0.86

Enterprise Value

5.239M

Cash

12.97M

Avg Qtr Burn

-7.458M

Insider Ownership

1.77%

Institutional Own.

74.61%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date